Yining (Jonathan) Zhao

Yining (Jonathan) Zhao has an extensive work experience in the pharmaceutical and biotechnology industry. Yining (Jonathan) is currently the Co-Founder and CEO of Heranova Lifesciences Holding. Prior to that, they served as a Board Member of Alebund Pharmaceuticals and IGENOMIX CHINA. In 2015, they co-founded Transcenta and held the position of Chairman of the Board. From 2015 to 2018, they were a Venture Partner at Lilly Asia Ventures. Before that, they worked at Amgen as the Executive Director of Global Commercial Operations. Yining (Jonathan) also held various roles at Pfizer including Asia Strategy Lead, Director of Biosimilar and Bioenhancement Development Unit, and Associate Research Fellow. Yining (Jonathan) Zhao began their career at Amgen as a Team Leader in Discovery Analytical Sciences.

Jonathan Zhao (Yining) completed their education history with a diverse range of academic achievements. Yining (Jonathan) began their educational journey by pursuing a Bachelor of Science degree in Medicinal Chemistry from Fudan University. This foundational degree was obtained between the years 1990 and 1994.

Building upon their undergraduate studies, Jonathan went on to pursue a Ph.D. at Ghent University, specializing in Analytical Chemistry. Yining (Jonathan)'sdoctoral studies spanned from 1995 to 1999, further honing their expertise in this field.

After completing their Ph.D., Jonathan sought to expand their knowledge outside the realm of chemistry and ventured into business studies. Yining (Jonathan) enrolled at the prestigious MIT Sloan School of Management, where they pursued a Master of Business Administration (MBA) degree from 2006 to 2008. During this period, they focused on Business, Management, Marketing, and Related Support Services to enhance their business acumen.

Overall, Jonathan Zhao's education history showcases a multidisciplinary approach, encompassing chemistry, business, and management disciplines.